RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Intravenous methylene blue as a rescue therapy in the management of refractory hypoxia in COVID-19 ARDS patients: A case series

Intravenous methylene blue as a rescue therapy in the management of refractory hypoxia in COVID-19 ARDS patients: A case series

Add to Collection
Case Reports N Mahale, P Godavarthy, S Marreddy… - Indian Journal of …, 2021 - ncbi.nlm.nih.gov

Chapter : Section17, Section23, Section24, Section4
Journal Year : 2021
Cited by : 8

… Pre-existing comorbidities were reported in 68% of patients with diabetes (14%), hypertension (16%), 30% of patients reported having both diabetes and hypertension, and 8% of …..... Read More

Keywords : ['intravenous methylene blue', 'rescue therapy', 'refractory hypoxia', 'case series', 'ard patient', 'management']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559741/
Google Scholar Link : https://scholar.google.com/scholar?cites=56509334735087569&as_sdt=5,33&sciodt=0,33&hl=en&num=20